TGFB1 and neoplasm: TGF-β released by the primary tumor can cause neutrophils to develop an N2-type pro-tumor phenotype, characterized by elevated arginase production and immunosuppressive effects on T cells (Fridlender et al., 2009; Eruslanov et al., 2014).